Approvals/CIMA-AEMPS/FLIXONASE 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL

Approved

STANDARD

FLIXONASE 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 8183867b9303bf55
Drug Cima Aemps Name: FLIXONASE 50 MICROGRAMOS/PULVERIZACION SUSPENSION PARA PULVERIZACION NASAL
Register Number: R2948IP3
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Elam Pharma Labs S.L.
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Authorization Date: 2025-02-27
Dosage Form: SUSPENSIÓN PARA PULVERIZACIÓN NASAL
Dose: 0,05 mg
Route Of Administration: VÍA NASAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

FLUTICASONA PROPIONATO

0,05 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 27, 2025

Approval ID

8183867b9303bf55

Type

Standard